India's bioeconomy to reach US $300 billion by 2030: Dr. Jitendra Singh

The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come

Aster DM Healthcare launches Pediatric & Geriatric Emergency Departments at Aster MIMS, Calicut

Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care

Aarti Drugs posts Q1 FY25 PAT lower at Rs. 33.3 Cr

Emcure Pharmaceuticals signs PPA with Sunsure Energy for solar power

The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants

Budget 2024-25: Industry expects push for reforms, R&D and fiscal incentives

Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23

Schneider Electric launches EcoStruxure for life science segment

Accelerating sustainability in Indian pharma industry

GSK acquires oligonucleotide drug startup Elsie

Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need

Moderna & Merck announce 3-year data for mRNA-4157 in combination with Keytruda

The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer

AstraZeneca plans $1.5 billion ADCs manufacturing facility in Singapore

Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs

AstraZeneca sets ambition to deliver US$ 80 billion revenue by 2030

Launch of 20 new medicines expected by 2030